Enhabit (NYSE:EHAB) and Ryman Healthcare (OTCMKTS:RYHTY) Financial Survey

Enhabit (NYSE:EHAB) and Ryman Healthcare (OTCMKTS:RYHTY) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends and risk.

Profitability

This table compares Enhabit and Ryman Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enhabit	-1.14%	3.91%	1.82%
Ryman Healthcare	N/A	N/A	N/A

Valuation and Earnings

This table compares Enhabit and Ryman Healthcare”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enhabit	$1.03 billion	0.46	-$156.20 million	($0.25)	-37.42
Ryman Healthcare	$451.64 million	N/A	-$259.39 million	N/A	N/A

Enhabit has higher revenue and earnings than Ryman Healthcare.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Enhabit and Ryman Healthcare, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enhabit	1	1	2	0	2.25
Ryman Healthcare	0	0	0	0	0.00

Enhabit currently has a consensus price target of $8.50, suggesting a potential downside of 9.14%. Given Enhabit’s stronger consensus rating and higher possible upside, equities analysts plainly believe Enhabit is more favorable than Ryman Healthcare.

Volatility & Risk

Enhabit has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500. Comparatively, Ryman Healthcare has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500.

Summary

Enhabit beats Ryman Healthcare on 8 of the 9 factors compared between the two stocks.

About Enhabit

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

About Ryman Healthcare

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hair salons, library, dining area, bar, lounges, croquet laws, shops, and movie theatre facilities. The company owns and operates retirement village units and care units. The company was founded in 1984 and is based in Christchurch, New Zealand.